nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—ABCB1—adrenal gland cancer	0.75	1	CbGaD
Haloperidol—Loperamide—POMC—adrenal gland cancer	0.00681	0.894	CrCbGaD
Haloperidol—HTR2A—sympathetic nervous system—adrenal gland cancer	0.00676	0.0818	CbGeAlD
Haloperidol—HTR2A—vein—adrenal gland cancer	0.00633	0.0765	CbGeAlD
Haloperidol—CYP2C19—urine—adrenal gland cancer	0.0058	0.0702	CbGeAlD
Haloperidol—CYP1A2—urine—adrenal gland cancer	0.00474	0.0573	CbGeAlD
Haloperidol—CYP2C9—urine—adrenal gland cancer	0.0045	0.0544	CbGeAlD
Haloperidol—HTR2A—urine—adrenal gland cancer	0.0037	0.0448	CbGeAlD
Haloperidol—CYP3A4—urine—adrenal gland cancer	0.00343	0.0415	CbGeAlD
Haloperidol—CYP2D6—urine—adrenal gland cancer	0.00337	0.0408	CbGeAlD
Haloperidol—CBR1—adrenal cortex—adrenal gland cancer	0.00311	0.0376	CbGeAlD
Haloperidol—CBR1—gonad—adrenal gland cancer	0.00258	0.0312	CbGeAlD
Haloperidol—CBR1—cardiac atrium—adrenal gland cancer	0.00257	0.0311	CbGeAlD
Haloperidol—H1F0—adrenal cortex—adrenal gland cancer	0.00255	0.0308	CbGeAlD
Haloperidol—CBR1—pituitary gland—adrenal gland cancer	0.00251	0.0304	CbGeAlD
Haloperidol—CBR1—adrenal gland—adrenal gland cancer	0.00225	0.0272	CbGeAlD
Haloperidol—H1F0—gonad—adrenal gland cancer	0.00211	0.0255	CbGeAlD
Haloperidol—H1F0—cardiac atrium—adrenal gland cancer	0.00211	0.0255	CbGeAlD
Haloperidol—H1F0—pituitary gland—adrenal gland cancer	0.00206	0.0249	CbGeAlD
Haloperidol—SIGMAR1—adrenal cortex—adrenal gland cancer	0.00184	0.0223	CbGeAlD
Haloperidol—H1F0—adrenal gland—adrenal gland cancer	0.00184	0.0223	CbGeAlD
Haloperidol—HTR2B—adrenal cortex—adrenal gland cancer	0.00184	0.0222	CbGeAlD
Haloperidol—SIGMAR1—cardiac atrium—adrenal gland cancer	0.00152	0.0184	CbGeAlD
Haloperidol—SIGMAR1—pituitary gland—adrenal gland cancer	0.00149	0.018	CbGeAlD
Haloperidol—SIGMAR1—adrenal gland—adrenal gland cancer	0.00133	0.0161	CbGeAlD
Haloperidol—HTR2B—adrenal gland—adrenal gland cancer	0.00133	0.016	CbGeAlD
Haloperidol—KCNH2—cardiac atrium—adrenal gland cancer	0.00121	0.0147	CbGeAlD
Haloperidol—DRD2—pituitary gland—adrenal gland cancer	0.0012	0.0145	CbGeAlD
Haloperidol—KCNH2—pituitary gland—adrenal gland cancer	0.00118	0.0143	CbGeAlD
Haloperidol—KCNH2—adrenal gland—adrenal gland cancer	0.00106	0.0128	CbGeAlD
Haloperidol—CYP1A1—cardiac atrium—adrenal gland cancer	0.00102	0.0124	CbGeAlD
Haloperidol—HRH1—adrenal gland—adrenal gland cancer	0.000848	0.0103	CbGeAlD
Haloperidol—HTR2A—gonad—adrenal gland cancer	0.000813	0.00983	CbGeAlD
Haloperidol—Loperamide—ABCB1—adrenal gland cancer	0.000811	0.106	CrCbGaD
Haloperidol—HTR2A—pituitary gland—adrenal gland cancer	0.000793	0.00959	CbGeAlD
Haloperidol—HTR2A—adrenal gland—adrenal gland cancer	0.000708	0.00857	CbGeAlD
Haloperidol—ABCB1—adrenal cortex—adrenal gland cancer	0.000643	0.00778	CbGeAlD
Haloperidol—ABCB1—gonad—adrenal gland cancer	0.000533	0.00644	CbGeAlD
Haloperidol—ABCB1—pituitary gland—adrenal gland cancer	0.00052	0.00629	CbGeAlD
Haloperidol—ABCB1—adrenal gland—adrenal gland cancer	0.000464	0.00561	CbGeAlD
Haloperidol—CYP1A2—Metabolism—SDHB—adrenal gland cancer	6.92e-05	0.000432	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	6.83e-05	0.000426	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—PRKACA—adrenal gland cancer	6.82e-05	0.000426	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PRKACA—adrenal gland cancer	6.62e-05	0.000413	CbGpPWpGaD
Haloperidol—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	6.56e-05	0.00041	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	6.49e-05	0.000405	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.48e-05	0.000405	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.47e-05	0.000404	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	6.41e-05	0.0004	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	6.38e-05	0.000398	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—POMC—adrenal gland cancer	6.37e-05	0.000398	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	6.37e-05	0.000398	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—CDC42—adrenal gland cancer	6.37e-05	0.000397	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	6.36e-05	0.000397	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	6.31e-05	0.000394	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—GNRH1—adrenal gland cancer	6.3e-05	0.000393	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PRKACA—adrenal gland cancer	6.26e-05	0.000391	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—POMC—adrenal gland cancer	6.24e-05	0.000389	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	6.2e-05	0.000387	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—POMC—adrenal gland cancer	6.14e-05	0.000383	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PRKACA—adrenal gland cancer	6.13e-05	0.000383	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	6.1e-05	0.000381	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—GNAS—adrenal gland cancer	6.09e-05	0.00038	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PRKACA—adrenal gland cancer	6.04e-05	0.000377	CbGpPWpGaD
Haloperidol—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	5.97e-05	0.000373	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	5.89e-05	0.000368	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	5.87e-05	0.000366	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—POMC—adrenal gland cancer	5.86e-05	0.000366	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	5.8e-05	0.000362	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—POMC—adrenal gland cancer	5.79e-05	0.000361	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—CDC42—adrenal gland cancer	5.78e-05	0.000361	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	5.77e-05	0.00036	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PRKACA—adrenal gland cancer	5.76e-05	0.00036	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SPRY2—adrenal gland cancer	5.76e-05	0.000359	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—RRM1—adrenal gland cancer	5.72e-05	0.000357	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—SDHD—adrenal gland cancer	5.72e-05	0.000357	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	5.72e-05	0.000357	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—POMC—adrenal gland cancer	5.67e-05	0.000354	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	5.63e-05	0.000351	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	5.62e-05	0.000351	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	5.61e-05	0.00035	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—RRM1—adrenal gland cancer	5.58e-05	0.000348	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—SDHD—adrenal gland cancer	5.58e-05	0.000348	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—POMC—adrenal gland cancer	5.58e-05	0.000348	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	5.57e-05	0.000347	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	5.54e-05	0.000346	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—POMC—adrenal gland cancer	5.53e-05	0.000345	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	5.53e-05	0.000345	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—MED12—adrenal gland cancer	5.52e-05	0.000344	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—POMC—adrenal gland cancer	5.45e-05	0.00034	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.44e-05	0.00034	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PRKACA—adrenal gland cancer	5.43e-05	0.000339	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	5.37e-05	0.000335	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—GNAS—adrenal gland cancer	5.37e-05	0.000335	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PRKACA—adrenal gland cancer	5.36e-05	0.000335	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SDHB—adrenal gland cancer	5.34e-05	0.000333	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—POMC—adrenal gland cancer	5.32e-05	0.000332	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CDC42—adrenal gland cancer	5.31e-05	0.000332	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	5.29e-05	0.00033	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	5.28e-05	0.000329	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—ABCB1—adrenal gland cancer	5.27e-05	0.000329	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—RRM1—adrenal gland cancer	5.26e-05	0.000328	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—SDHD—adrenal gland cancer	5.26e-05	0.000328	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.26e-05	0.000328	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—RRM1—adrenal gland cancer	5.22e-05	0.000326	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—SDHD—adrenal gland cancer	5.22e-05	0.000326	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—MED12—adrenal gland cancer	5.21e-05	0.000325	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CDC42—adrenal gland cancer	5.2e-05	0.000325	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IGF2—adrenal gland cancer	5.12e-05	0.00032	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CDC42—adrenal gland cancer	5.12e-05	0.00032	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—GNAS—adrenal gland cancer	5.08e-05	0.000317	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	5.04e-05	0.000314	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—POMC—adrenal gland cancer	5.02e-05	0.000313	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	5.01e-05	0.000313	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	4.97e-05	0.00031	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—POMC—adrenal gland cancer	4.95e-05	0.000309	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IGF1R—adrenal gland cancer	4.95e-05	0.000309	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IGF2—adrenal gland cancer	4.93e-05	0.000308	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—GNAS—adrenal gland cancer	4.89e-05	0.000305	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CDC42—adrenal gland cancer	4.89e-05	0.000305	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	4.85e-05	0.000303	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IGF1R—adrenal gland cancer	4.77e-05	0.000298	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IGF2—adrenal gland cancer	4.71e-05	0.000294	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—GNAS—adrenal gland cancer	4.67e-05	0.000291	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.66e-05	0.000291	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CDC42—adrenal gland cancer	4.61e-05	0.000288	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	4.55e-05	0.000284	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CDC42—adrenal gland cancer	4.55e-05	0.000284	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—GNAS—adrenal gland cancer	4.51e-05	0.000282	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—RRM1—adrenal gland cancer	4.46e-05	0.000278	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—SDHD—adrenal gland cancer	4.46e-05	0.000278	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IGF2—adrenal gland cancer	4.44e-05	0.000277	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	4.43e-05	0.000276	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—GNAS—adrenal gland cancer	4.4e-05	0.000275	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IGF2—adrenal gland cancer	4.38e-05	0.000274	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—GNAS—adrenal gland cancer	4.35e-05	0.000271	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IGF1R—adrenal gland cancer	4.3e-05	0.000268	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—MED12—adrenal gland cancer	4.27e-05	0.000266	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TERT—adrenal gland cancer	4.26e-05	0.000266	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IGF1R—adrenal gland cancer	4.24e-05	0.000264	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.23e-05	0.000264	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	4.17e-05	0.00026	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	4.17e-05	0.00026	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—MED12—adrenal gland cancer	4.16e-05	0.00026	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TERT—adrenal gland cancer	4.11e-05	0.000256	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	4.11e-05	0.000256	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	4.1e-05	0.000256	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	4.1e-05	0.000256	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	4.04e-05	0.000252	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	4.03e-05	0.000251	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	4.02e-05	0.000251	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—MED12—adrenal gland cancer	3.92e-05	0.000245	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	3.92e-05	0.000245	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—MED12—adrenal gland cancer	3.89e-05	0.000243	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.81e-05	0.000238	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PRKACA—adrenal gland cancer	3.8e-05	0.000237	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	3.79e-05	0.000237	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	3.73e-05	0.000233	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	3.72e-05	0.000232	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.72e-05	0.000232	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—BAD—adrenal gland cancer	3.71e-05	0.000231	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TERT—adrenal gland cancer	3.7e-05	0.000231	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TERT—adrenal gland cancer	3.65e-05	0.000228	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	3.63e-05	0.000227	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—POMC—adrenal gland cancer	3.61e-05	0.000225	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—BAD—adrenal gland cancer	3.57e-05	0.000223	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	3.48e-05	0.000217	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.48e-05	0.000217	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3.44e-05	0.000215	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3.44e-05	0.000215	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	3.42e-05	0.000214	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	3.42e-05	0.000213	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	3.42e-05	0.000213	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	3.41e-05	0.000213	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	3.38e-05	0.000211	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	3.35e-05	0.000209	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	3.35e-05	0.000209	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	3.32e-05	0.000208	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—MED12—adrenal gland cancer	3.32e-05	0.000207	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	3.31e-05	0.000206	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	3.3e-05	0.000206	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—POMC—adrenal gland cancer	3.29e-05	0.000206	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	3.29e-05	0.000206	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	3.27e-05	0.000204	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	3.27e-05	0.000204	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	3.26e-05	0.000204	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GNAS—adrenal gland cancer	3.26e-05	0.000204	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—BRAF—adrenal gland cancer	3.25e-05	0.000203	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	3.24e-05	0.000202	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—BAD—adrenal gland cancer	3.22e-05	0.000201	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	3.2e-05	0.0002	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	3.2e-05	0.0002	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	3.19e-05	0.000199	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	3.18e-05	0.000199	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—BAD—adrenal gland cancer	3.17e-05	0.000198	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—EGFR—adrenal gland cancer	3.15e-05	0.000197	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	3.14e-05	0.000196	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	3.11e-05	0.000194	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	3.1e-05	0.000194	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GNAS—adrenal gland cancer	3.08e-05	0.000192	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.04e-05	0.00019	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—POMC—adrenal gland cancer	3.04e-05	0.00019	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PRKACA—adrenal gland cancer	3.04e-05	0.00019	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ABCB1—adrenal gland cancer	3.02e-05	0.000189	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	3.01e-05	0.000188	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.97e-05	0.000185	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—POMC—adrenal gland cancer	2.97e-05	0.000185	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	2.93e-05	0.000183	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—POMC—adrenal gland cancer	2.93e-05	0.000183	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	2.89e-05	0.00018	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PTGS2—adrenal gland cancer	2.88e-05	0.00018	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.86e-05	0.000179	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	2.84e-05	0.000177	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	2.84e-05	0.000177	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	2.8e-05	0.000175	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TERT—adrenal gland cancer	2.79e-05	0.000174	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.77e-05	0.000173	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	2.75e-05	0.000171	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TERT—adrenal gland cancer	2.74e-05	0.000171	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.56e-05	0.00016	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GNAS—adrenal gland cancer	2.52e-05	0.000157	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	2.47e-05	0.000154	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.46e-05	0.000154	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	2.44e-05	0.000152	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—BAD—adrenal gland cancer	2.43e-05	0.000152	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	2.42e-05	0.000151	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	2.42e-05	0.000151	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	2.39e-05	0.000149	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	2.39e-05	0.000149	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—BAD—adrenal gland cancer	2.38e-05	0.000149	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.37e-05	0.000148	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CTNNB1—adrenal gland cancer	2.35e-05	0.000147	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GNAS—adrenal gland cancer	2.32e-05	0.000145	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GNAS—adrenal gland cancer	2.3e-05	0.000144	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	2.28e-05	0.000142	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	2.26e-05	0.000141	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	2.24e-05	0.00014	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—POMC—adrenal gland cancer	2.24e-05	0.00014	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	2.21e-05	0.000138	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	2.2e-05	0.000137	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—POMC—adrenal gland cancer	2.2e-05	0.000137	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—POMC—adrenal gland cancer	2.2e-05	0.000137	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	2.18e-05	0.000136	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	2.17e-05	0.000135	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	2.14e-05	0.000134	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.12e-05	0.000132	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	2.11e-05	0.000132	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	2.1e-05	0.000131	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	2.09e-05	0.00013	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—POMC—adrenal gland cancer	2.08e-05	0.00013	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GNAS—adrenal gland cancer	1.96e-05	0.000123	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	1.93e-05	0.000121	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	1.93e-05	0.00012	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	1.89e-05	0.000118	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.87e-05	0.000117	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—EGFR—adrenal gland cancer	1.86e-05	0.000116	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	1.78e-05	0.000111	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	1.75e-05	0.000109	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.7e-05	0.000106	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	1.68e-05	0.000105	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—POMC—adrenal gland cancer	1.66e-05	0.000103	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—adrenal gland cancer	1.66e-05	0.000103	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	1.65e-05	0.000103	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	1.62e-05	0.000101	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.6e-05	9.97e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	1.59e-05	9.92e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.57e-05	9.81e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.57e-05	9.79e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TP53—adrenal gland cancer	1.56e-05	9.76e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.56e-05	9.75e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—POMC—adrenal gland cancer	1.55e-05	9.66e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.52e-05	9.46e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	1.49e-05	9.32e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.49e-05	9.29e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TP53—adrenal gland cancer	1.41e-05	8.79e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TP53—adrenal gland cancer	1.39e-05	8.67e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1.35e-05	8.45e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—POMC—adrenal gland cancer	1.32e-05	8.26e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.32e-05	8.25e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	1.27e-05	7.9e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.25e-05	7.77e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	1.25e-05	7.77e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	1.24e-05	7.76e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	1.23e-05	7.71e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TP53—adrenal gland cancer	1.06e-05	6.63e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	1.06e-05	6.59e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	1.05e-05	6.53e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TP53—adrenal gland cancer	1.04e-05	6.51e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.02e-05	6.37e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	8.14e-06	5.08e-05	CbGpPWpGaD
